Gross Margin
25.32%vs Specialty Chemicals peers Updated Aug 20, 2026Profit Margin
5.74%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
8.88%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
4.14%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
5.56%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
17.33BCNY2.57B · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
6.26CNYUpdated Aug 20, 2026Quarterly Revenue Growth
2.40%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
4.64BCNY689.68M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
1.61BCNY239.30M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
995.25MCNY147.82M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
-34.30%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
3.01BCNY447.25M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
208.26MCNY30.93M · vs all stocks (USD) Updated Aug 20, 2026Trailing Annual Dividend Rate
0.1000CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.16%Updated Aug 20, 20265-Year Average Dividend Yield
1.62%Updated Aug 20, 2026Payout Ratio
47.50%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 27.78%.Updated Aug 20, 2026Minority Interest (Equity)
31.81MCNYFY2025 · Dec 31, 2025Revenue
17.23BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
12.35BCNYFY2025 · Dec 31, 2025Gross Profit
4.88BCNYFY2025 · Dec 31, 2025Operating Income
2.05BCNY304.03M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
1.57BCNYFY2025 · Dec 31, 2025Income Tax Expense
413.81MCNYFY2025 · Dec 31, 2025Net Income
1.16BCNYFY2025 · Dec 31, 2025EBIT
1.62BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.39BCNYFY2025 · Dec 31, 2025Research & Development
456.12MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
-371.74MCNYFY2025 · Dec 31, 2025Other Operating Expenses
1.57BCNYFY2025 · Dec 31, 2025Non-operating Interest Income
89.23MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
54.22MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.68BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.68BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.16BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.16MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.21BCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.49BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.27BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.16BCNYFY2025 · Dec 31, 2025Other Non-cash Items
34.26MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-130.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
148.57MCNYFY2025 · Dec 31, 2025Capital Expenditures
-3.70BCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.83MCNYFY2025 · Dec 31, 2025Sale of Investments
94.56MCNYFY2025 · Dec 31, 2025Other Investing Activity
356.55MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.25BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.42BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-767.32MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-578.46MCNYFY2025 · Dec 31, 2025Other Financing Charges
2.84BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
2.91BCNYFY2025 · Dec 31, 2025